Efficacy studies of a trivalent vaccine containing pcv-2a, pcv-2b genotypes and mycoplasma hyopneumoniae when administered at 3 days of age and 3 weeks later against porcine circovirus 2 (pcv-2) infection

HIGHLIGHTS

• who: Patricia Pleguezuelos et al. from the Centre de Recerca en Sanitat Animal (IRTA-CReSA), Campus de la Universitat Autu00f2noma de Barcelona, Bellaterra, Barcelona, Spain have published the Article: Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection, in the Journal: Vaccines 2022, x of /2022/
• what: This work aimed to elucidate the efficacy of a novel trivalent vaccine containing inactivated Porcine Circovirus 1 (PCV-1)/PCV-2a chimera (cPCV-2a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.